300595.SZ
欧普康视
SZSE · Healthcare · C 制造业 · CN
CNY 10.71
−2.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8B | 1.9B | 1.8B | 1.7B | 1.5B |
| Cost of Revenue | 527.7M | 512.6M | 481.3M | 438.1M | 352.5M |
| Gross Profit | 1.3B | 1.3B | 1.3B | 1.3B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | 43.8M | 43.9M | 42.3M | 40.3M | 33.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 123.5M | 128.8M | 109.2M | 117.9M | 126.3M |
| Selling & Marketing Expense | 524.3M | 520.7M | 461.4M | 376.9M | 295.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 717.7M | 720.3M | 635.8M | 548.7M | 461.4M |
| Cost and Expenses | 1.2B | 1.2B | 1.1B | 986.8M | 814.0M |
| Operating Income (EBIT) | 636.9M | 649.8M | 739.3M | 855.7M | 798.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 630.6M | 643.1M | 727.9M | 847.1M | 795.5M |
| Income Tax Expense | 96.2M | 99.2M | 106.1M | 118.1M | 98.7M |
| Bottom Line | |||||
| Net Income | 465.4M | 479.5M | 572.2M | 666.6M | 623.8M |
| Earnings from Cont. Ops | 534.4M | 543.9M | 621.8M | 729.0M | 696.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 465.4M | 479.5M | 572.2M | 666.6M | 623.8M |
| Per Share | |||||
| Basic EPS | CN¥0.52 | CN¥0.54 | CN¥0.64 | CN¥0.75 | CN¥0.72 |
| Diluted EPS | CN¥0.52 | CN¥0.54 | CN¥0.64 | CN¥0.75 | CN¥0.72 |
| Revenue Per Share | CN¥2.06 | CN¥2.08 | CN¥2.03 | CN¥1.94 | CN¥1.75 |
| Shares | |||||
| Basic Shares Outstanding | 893.0M | 893.0M | 893.0M | 893.3M | 870.8M |
| Diluted Shares Outstanding | 893.0M | 893.0M | 893.0M | 893.3M | 870.8M |
| Profitability Metrics | |||||
| EBITDA | — | 738.8M | 807.3M | 909.7M | 846.4M |
| D&A | — | 89.0M | 68.1M | 54.1M | 47.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026